POLYMED.NS Balance Sheet
Poly Medicure Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:43
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹5.87 Bn | ₹8.19 Bn | ₹10.38 Bn | ₹12.55 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹0.73 Bn | ₹0.67 Bn | ₹0.90 Bn | ₹0.91 Bn | CapitalWorkInProgress |
| Goodwill | ₹0.29 Bn | ₹0.29 Bn | ₹0.29 Bn | ₹2.74 Bn | Goodwill |
| Other Intangible Assets | ₹0.16 Bn | ₹0.16 Bn | ₹0.15 Bn | ₹1.57 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Bn | ₹0.20 Bn | ₹0.07 Bn | ₹0.01 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹0.40 Bn | ₹0.37 Bn | ₹0.51 Bn | ₹0.84 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹7.70 Bn | ₹10.17 Bn | ₹12.75 Bn | ₹19.77 Bn | NoncurrentAssets |
| Inventories | ₹2.09 Bn | ₹2.21 Bn | ₹2.86 Bn | ₹4.34 Bn | Inventories |
| Trade Receivables | ₹2.35 Bn | ₹2.70 Bn | ₹3.50 Bn | ₹5.31 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹0.07 Bn | ₹0.12 Bn | ₹0.09 Bn | ₹0.51 Bn | CashAndCashEquivalents |
| Current Investments | ₹1.19 Bn | ₹1.40 Bn | ₹10.57 Bn | ₹7.39 Bn | CurrentInvestments |
| Other Current Assets | ₹0.54 Bn | ₹0.51 Bn | ₹0.66 Bn | ₹1.03 Bn | OtherCurrentAssets |
| Total Current Assets | ₹8.07 Bn | ₹8.42 Bn | ₹19.17 Bn | ₹19.42 Bn | CurrentAssets |
| Total Assets | ₹15.77 Bn | ₹18.59 Bn | ₹31.92 Bn | ₹39.19 Bn | Assets |
| Equity Share Capital | ₹0.48 Bn | ₹0.48 Bn | ₹0.51 Bn | ₹0.51 Bn | EquityShareCapital |
| Other Equity | ₹11.94 Bn | ₹14.22 Bn | ₹27.15 Bn | ₹30.55 Bn | OtherEquity |
| Equity Attributable to Owners | ₹12.42 Bn | ₹14.70 Bn | ₹27.66 Bn | ₹31.06 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | ₹0.43 Bn | NonControllingInterest |
| Total Equity | ₹12.42 Bn | ₹14.70 Bn | ₹27.66 Bn | ₹31.49 Bn | Equity |
| Long-term Borrowings | ₹0.18 Bn | ₹0.01 Bn | ₹0.00 Bn | ₹0.52 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹0.42 Bn | ₹0.37 Bn | ₹0.57 Bn | ₹1.94 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹1.29 Bn | ₹1.69 Bn | ₹1.78 Bn | ₹2.90 Bn | BorrowingsCurrent |
| Trade Payables | ₹0.92 Bn | ₹0.96 Bn | ₹0.86 Bn | ₹1.23 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹0.33 Bn | ₹0.28 Bn | ₹0.29 Bn | ₹0.56 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹2.93 Bn | ₹3.51 Bn | ₹3.70 Bn | ₹5.76 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹15.77 Bn | ₹18.59 Bn | ₹31.92 Bn | ₹39.19 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from POLYMED.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).